Drug Design, Development and Therapy

Dove Medical Press

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Drug Design, Development and Therapy is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,940 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Dove Medical Press
ISSN
1177-8881
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
3,940 USD
Articles in DOAJ
5588
Declared review time
16 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2008-08-15
  • MEDLINE · 2007-01-01
  • PUBMED · 2007-10-01
Indexing
DOAJ · MEDLINE · PUBMED
APC
3,940 USD
Declared review time (DOAJ)
16 weeks
Actual review time (measured)
66 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

5588

Most recent article

last month

Average review time (journal-declared via DOAJ)

16weeks

Works in OpenAlex

5705

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

128

i10-index

3292

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-04-27
Added to DOAJ
2008-08-15
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
76%
ORCID iDs in current deposits
78%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101475745
Classification2

Subjects (DOAJ)

Medicine: Therapeutics. Pharmacology

LCC codes

RM1-950

Subject areas

  • Anesthesia and Sedative Agents
  • Anesthesia and Sedative Agents
  • Anesthesia and Pain Management
  • Anesthesia and Pain Management
  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
  • Nausea and vomiting management
  • Nausea and vomiting management
Show all subjects (50)
  • Intensive Care Unit Cognitive Disorders
  • Drug Solubulity and Delivery Systems
  • Drug Solubulity and Delivery Systems
  • Intensive Care Unit Cognitive Disorders
  • Traditional Chinese Medicine Analysis
  • Traditional Chinese Medicine Analysis
  • Diabetes Treatment and Management
  • Diabetes Treatment and Management
  • Cancer, Stress, Anesthesia, and Immune Response
  • Nanoparticle-Based Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • Enhanced Recovery After Surgery
  • Cancer, Stress, Anesthesia, and Immune Response
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Pharmacological Effects of Natural Compounds
  • Pharmacological Effects of Natural Compounds
  • Anesthesia and Neurotoxicity Research
  • Enhanced Recovery After Surgery
  • Anesthesia and Neurotoxicity Research
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Treatment of Major Depression
  • Antibiotics Pharmacokinetics and Efficacy
  • Curcumin's Biomedical Applications
  • Pharmacogenetics and Drug Metabolism
  • Pharmacogenetics and Drug Metabolism
  • Treatment of Major Depression
  • Antibiotics Pharmacokinetics and Efficacy
  • Curcumin's Biomedical Applications
  • Natural product bioactivities and synthesis
  • Autophagy in Disease and Therapy
  • Liver Disease Diagnosis and Treatment
  • Bone Metabolism and Diseases
  • Bone Metabolism and Diseases
  • Autophagy in Disease and Therapy
  • Flavonoids in Medical Research
  • Chronic Kidney Disease and Diabetes
  • Chronic Kidney Disease and Diabetes
  • Rheumatoid Arthritis Research and Therapies
  • Natural product bioactivities and synthesis
  • Liver Disease Diagnosis and Treatment

Keywords (DOAJ)

  • drug design
  • drug safety
  • drug development
  • pharmaecuticals

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: